Combination therapy
MA40367AUndetermined Publication Date: 2017-05-10IMCLONE LLC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA40367
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2014-07-03
- Filing Date
- 2015-06-26
- Publication Date
- 2017-05-10
Abstract
Combination of human antibodies that bind to human platelet-derived growth factor receptor alpha (pdgfr alpha), preferably olaratumab, and doxorubicin as a medicament for the treatment of soft tissue sarcoma.
Need to check novelty before this filing date? Find Prior Art